LSI:FRA
CK Life Sciences Intl (Holdings) Inc
€0.055
arrow_downward
-0.90%(-0.00050) 1D
Oct 23, 9:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LSI...
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
4.66B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.06
No. of employees
2K
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
4.66B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.06
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
38 minutes ago
Nasdaq Strengthens Asia-Pacific Leadership Team
Moomoo
·
20 minutes ago
Following a two-week slump on the Nasdaq, faith in AI is faltering as capital shifts from chasing growth to scrutinizing AI investment returns.
Foreign Policy Journal
·
39 minutes ago
Super Micro Computer (NASDAQ: SMCI) Stock Trades At Deep Discount Despite Strong AI Demand And Raised Guidance
Bloomberg.com
·
11 hours ago
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc